About Antigoni Manousopoulou
Form D filings for Proteas Bioanalytics in 2023 list Antigoni Manousopoulou as director.
Antigoni Manousopoulou first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Antigoni Manousopoulou in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Antigoni Manousopoulou works with at each company, as listed on that company's latest Form D.
Proteas Bioanalytics Inc. · Form D, Mar 13, 2023
VD
Valerie Darling
Director
SG
Spiros Garbis
Chief Executive Officer and director